US Patent

US8822424 — Antibacterial aminoglycoside analogs

Formulation · Assigned to Achaogen Inc · Expires 2028-11-21 · 3y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a class of antibacterial compounds, including their preparation and use in pharmaceutical compositions, specifically covering compounds with a defined structure and certain substituents.

USPTO Abstract

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q 1 , Q 2 , Q 3 , R 8 and R 9 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
US8822424
Jurisdiction
US
Classification
Formulation
Expires
2028-11-21
Drug substance claim
No
Drug product claim
Yes
Assignee
Achaogen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.